FDA Clearance Tracker · P170012
HEMOBLAST Bellows
Last checked: Nov 20, 2026Latest source record: Dec 15, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2017
Approved
Time to decision
260 days
Received Mar 30, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170012
- Device name
- HEMOBLAST Bellows
- Applicant
- Dilon Technologies, Inc.
- Applicant location
- Newport News, VA
- Received
- Mar 30, 2017
- Decided
- Dec 15, 2017
- Decision
- Approved
- Supplements
- 32 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
Approval of the Hemoblast Bellows. This device is indicated for surgical procedures as an adjunct to hemostasis when control of minimal, mild, and moderate bleeding by conventional procedures is ineffective or impractical, except in neurosurgical, ophthalmic, and urological procedures.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PMX. The earliest in FDA's data is P990009, decided Dec 8, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Dilon Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.